Evaluating the Efficacy of the Wearable Cardioverter-Defibrillator

Activity Description

This educational activity evaluates the efficacy of the Wearable Cardioverter-Defibrillator through an in-depth analysis of the VEST trial; including an interpretation of outcomes data, and an assessment of the clinical implications on daily practice based upon the results.

Access Presentation

Webcast

Evaluating the Efficacy of the Wearable Cardioverter-Defibrillator: What Do the Results of the VEST Trial Mean for Clinical Practice? Access >>
Deepak Bhatt, MD, MPH and Jeffrey Olgin, MD

VEST Trial in Perspective: “Not perfect, so let’s do nothing?” Access >>
J. Rod Gimbel, MD, FACC, FHRS

Evaluating the Efficacy of the Wearable Cardioverter-Defibrillator: What Do the Results of the VEST Trial Mean for Clinical Practice?
Deepak Bhatt, MD, MPH and Jeffrey Olgin, MD

Click on each chapter title listed below to view discussion on that topic.

VEST Trial in Perspective: “Not perfect, so let’s do nothing?”
J. Rod Gimbel, MD, FACC, FHRS

Commercial Supporter

This activity is supported by an educational grant from ZOLL

Joint-Providers

MediaSphere Medical, LLC and Ciné-Med

Faculty

	Deepak Bhatt, MD, MPH Professor at Harvard Executive Director of Interventional Cardiovascular Programs Brigham and Women's Hospital Boston, MA
	Jeffrey Olgin, MD Co-Director of the Heart and Vascular Center Chief of Cardiology University of California, San Francisco San Francisco, CA
	J. Rod Gimbel, MD, FACC, FHRS Staff Electrophysiologist Columbia-St. Mary’s Hospital System Ascension-Wisconsin